Pharma Focus Asia
Eppendorf Bioprocess Solutions


This section presents pharmaceutical projects that are announced from time-to-time around the world.

GeminiBio Plans to Contruct New Liquid Manufacturing Facility

GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA

Meissner Corporation Invests US$250 million to Construct New Manufacturing Facility

Meissner Corporation plans to construct new manufacturing facility The new facility will be loacted at Georgia, USA

Cambrex Constructs New Stability Storage Facility in Belgium, Europe

Cambrex plans to construct new stability storage facility to the pharmaceutical, medical device and life sciences industries across Europe

Catalent Invests US$20 million to Expand in Schorndorf, Germany

IntroductionCatalent invests US$20 million to expand its clinical supply facility The new facility will be located in Schorndorf, Germany

PharmaBlock Plans to Expand New R&D Facility Operations in Pennsylvania, USA

PharmaBlock plans to expand its RD operations to deliver GMP projects with the opening of new facility

Pharmaron Invests US$189.79 million (£151 million) to Open New Manufacturing Facility in UK

Pharmaron plans to open a new gene production facility to expand its viral vector and DNA manufacturing facilities to more than 8,000 square metres

Evonik Constructs New Pharmaceutical Lipids Facility in Indiana, USA

Evonik with an investment of US$220 million plans for the construction of new pharmaceutical lipid production facility The new facility will be located in Indiana, United States The new facility is expected to provide industry with access to critical adjuvants needed for mRNA vaccines and other nucleic acid therapies

Samsung Biologics Invests US $1.46 billion (KRW 1.9 trillion) for the Construction of Fifth New Plant

Samsung Biologics plans for the contruction of fifth new plant The new site will be located at Songdo, South Korea The new facility is the second Bio campus covering an area of 96,000m2 and holding a capacity of 180,000 litres

AtomVie Global Radiopharma to Open New Radiotherapeutics Facility in Ontario, Canada

AtomVie Global Radiopharma in partnership with Panattoni Development plans for the construction of new stateoftheart radiotherapeutics facility The new stateoftheart facility which covers an area of 64,000 square feet is is designed for largescale clinical and commercial GMP

Fluor Corporation Invests US$725 million to Open New Manufacturing Facility

Fluor Corporation plans to open new oligonucleotide therapeutics manufacturing facility The new facility will be located in Colorado, USA The manufacturing facility laid at 275,000 squarefoot will house two manufacturing lines to double manufacturing capability

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology